Compare Ascendis Pharma A/S (ASND) vs TeraWulf Inc (WULF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs TeraWulf Inc — how do they compare? Ascendis Pharma A/S trades at $255.51 (market cap $16.67B), while TeraWulf Inc trades at $17.71 (market cap $8.35B). The key difference: Ascendis Pharma A/S is the larger of the two by market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, TeraWulf Inc nearer its low. Which is the better fit depends on your goals.
| ASND | WULF | |
|---|---|---|
Market Cap | $16.67B | $8.35B |
Sector | Health | Technology |
52-Week High | $277.18 | $28.98 |
52-Week Low | $189.74 | $5.24 |
Enterprise Value | $17.04B | $10.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →
